Skip to main content
CriticalFDAfda-F-2152-2016CONTAMINATION

Michel Cordon Bleu, Inc. Fresh Smoked Trout With Herbs, sold in various sizes

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
479
Recall Date
February 18, 2016
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2152-2016.

Product is being recalled due to potential Clostridium botulinum contamination.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2152-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Michel Cordon Bleu Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2152-2016.

Michel Cordon Bleu Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Michel Cordon Bleu Inc Recall FAQ

Michel Cordon Bleu Inc is the subject of a food safety report: Michel Cordon Bleu, Inc. Fresh Smoked Trout With Herbs, sold in various sizes. The notice was published on February 18, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 479 units are potentially affected.